The Technical Story of Prime Medicine Inc (PRME) Stock
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Prime Medicine Inc (NASDAQ:PRME) Stock is trading Lower -30.66% From 200-Day SMA
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Prime Medicine Inc (PRME) Stock Is Looking Attractive
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
A positive surprise is on the way: Prime Medicine Inc (PRME) Stock
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Prime Medicine Inc (PRME) Stock: Pessimism is a stepping stone to opportunity
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Prime Medicine Inc (PRME) Stock is the one stock you should own forever
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Analyzing Prime Medicine Inc’s (PRME) Stock earnings per share and revenue
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
Prime Medicine Inc (PRME) Stock to return to profitability in the near future
H.C. Wainwright raised the price target for the Prime Medicine Inc (NASDAQ:PRME) stock to “a Buy”. The rating was released on May 20, 2024, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $17. In their research brief published April 03, 2024, […]
